COVID-19, A Clinical Syndrome Manifesting as Hypersensitivity Pneumonitis
- PMID: 32153144
- PMCID: PMC7113449
- DOI: 10.3947/ic.2020.52.1.110
COVID-19, A Clinical Syndrome Manifesting as Hypersensitivity Pneumonitis
Keywords: COVID-19; Coronavirus; Hypersensitivity pneumonitis; SARS-CoV-2.
Conflict of interest statement
YGS is an editorial board of the journal Infect Chemother. However, he did not involve in the reviewer selection, evaluation, and decision making of this article. Otherwise, no conflicts of interest were reported.
Comment in
-
COVID-19, A and Hypersensitivity Pneumonitis.Infect Chemother. 2020 Jun;52(2):216. doi: 10.3947/ic.2020.52.2.216. Epub 2020 Apr 16. Infect Chemother. 2020. PMID: 32342675 Free PMC article. No abstract available.
References
-
- Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72,314 cases from the Chinese center for disease control and prevention. JAMA. 2020 [Epub ahead of print] - PubMed
-
- King TE., Jr Hypersensitivity pneumonitis (extrinsic allergic alveolitis): Epidemiology, causes, and pathogenesis. [Assecced 7 March 2020]. Available at: https://www.uptodate.com/contents/hypersensitivity-pneumonitis-extrinsic....
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
